You are now being logged in using your Facebook credentials

UKidney: Official Educational Partner of the International Society of Nephrology (ISN)

Login With Facebook
Return to:
Wednesday, 28 September 2011 15:01

Latest Developments in Bone Mineral Metabolism Featured

Written by  Dr. Myles Wolf
Rate this item
(1 Vote)

This presentation is part of the Prevention in Renal Disease Meeting, Toronto, 2011. For the entire program, please click here

 

Myles S. Wolf, MD, MMSc

The primary focus of Dr. Wolf’s research is to understand mechanisms of disordered mineral metabolism in patients with chronic kidney disease (CKD) including the role of fibroblast growth factor-23 (FGF23), vitamin D and parathyroid hormone in phosphorus and calcium metabolism in CKD. In addition, Blacks and Hispanics bear a disproportionate burden of CKD with more rapid progression to dialysis and worse CVD outcomes.

Read 633 times Last modified on Wednesday, 11 January 2012 01:07
Published in Prevention in Renal Disease Conference 2011
Tagged under

Related items

More in this category: « Prevention of AKI in the elderly Overcoming barriers to end-of-life decision making »

1 comment

  • Comment Link Randy Caron Wednesday, 11 January 2012 03:51 posted by Randy Caron

    Excellent talk by Dr. Wolf

    Report

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

back to top